Verve Therapeutics saw the highest growth of 2.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Verve Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Verve Therapeutics has been focused on protecting inventions in European Patent Office(EPO) with three publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 14% of filings. The United Kingdom(GB), United States(US), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Verve Therapeutics is filings its patents..
Regeneron Pharmaceuticals could be the strongest competitor for Verve Therapeutics
Patents related to nanomedicine and genomics lead Verve Therapeutics's portfolio
Verve Therapeutics has the highest number of patents in nanomedicine followed by, genomics and rare diseases. For nanomedicine, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Cardiovascular disease related patents lead Verve Therapeutics portfolio followed by atherosclerosis, and cardiomyopathy
Verve Therapeutics has highest number of patents in cardiovascular disease followed by atherosclerosis, cardiomyopathy, coronary disease, and metabolic disorders.
For comprehensive analysis of Verve Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
